Indication

Radiotoxicity

1 clinical trial

2 products

Clinical trial

Technetium-99m/Rhenium-188 Labeled Anti-HER2 Single Domain Antibody (99mTc/188Re-NM-02) for HER2 Expression Detection and Radionuclide Therapy in Breast Cancer

Status: Recruiting, Estimated PCD: 2024-03-08

Product

Product